Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Baker Felix
Relationship:   Director, 10% Owner
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   20    
Direct Shares   927,207    

Indirect Shares

  141,861,898      
Direct Value   $81,660,525    

Indirect Value

  $12,932,114,466      
Total Shares   142,789,105      
Total Value   $13,013,774,992      


Incyte Corp
 $32,141,876 Seagen Inc
 $49,182,531 Synageva BioPharma Corp
 $0 Genomic Health Inc
 $18,271 Biocryst Pharmaceuticals Inc
 $301,214 Neurogene
 $16,634 Incyte Corp
 $32,141,876 Seagen Inc
 $49,182,531 Synageva BioPharma Corp
 $0 Genomic Health Inc
 $18,271 Biocryst Pharmaceuticals Inc
 $301,214 Neurogene
 $16,634
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    36   
    6    

     Stock price went up :

    15   
    6    
     Stock price went down :
    21   
    0    
   
     Gain/Loss Ratio :
   0.0   
   6.0   
     Percentage Gain/Loss :
   -24.3%
 18.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Incyte Corp INCY Director, 10% Owner 2023-09-29 559,963 2023-09-29 33,480,292    Premium*  
            Ardea Biosciences Inc RDEA Director, 10% Owner 2003-10-06 0 2012-02-01 116,454    Premium*  
            Seagen Inc SGEN Director, 10% Owner 2018-02-01 215,015 2018-02-01 44,355,335    Premium*  
            Synageva BioPharma Corp GEVA Director, 10% Owner 2015-06-22 100,503 2015-06-22 9,328,233    Premium*  
            Viropharma Inc VPHM 10% Owner 2005-01-31 0 2011-12-14 303,264    Premium*  
            Aceragen, Inc ACGN Director 0 2017-07-03 145,453    Premium*  
            Tapestry Pharmaceuticals Inc TPPHQ 10% Owner 0 2008-10-15 0    Premium*  
            Genomic Health Inc GHDX Director, 10% Owner 2012-10-01 288 2012-10-01 11,377,485    Premium*  
            Allos Therapeutics Inc ALTH 10% Owner 0 2009-02-06 1,629    Premium*  
            Biocryst Pharmaceuticals Inc BCRX 10% Owner 2016-08-16 46,918 2016-08-16 9,418,390    Premium*  
            Heron Therapeutics Inc HRTX 10% Owner 0 2011-06-30 5,266,568    Premium*  
            Adolor Corp ADLR 10% Owner 2010-04-26 0 2011-12-19 0    Premium*  
            Diadexus Inc DDXS 10% Owner 0 2010-07-28 140,525    Premium*  
            Pharmacyclics Inc PCYC 10% Owner 0 2011-08-22 1,809    Premium*  
            Ocera Therapeutics Inc OCRX 10% Owner 2012-03-12 0 2012-03-14 57,704    Premium*  
            XOMA Corporation XOMA Director, 10% Owner 2012-10-29 0 2012-10-29 480,639    Premium*  
            Neurogene NGNE 10% Owner 2015-08-07 4,520 0    Premium*  
            Invitae Corp NVTA 10% Owner 0 2015-08-27 6,554,967    Premium*  
            Bellicum Pharmaceuticals, Inc BLCM 10% Owner 0 2015-12-24 4,865,647    Premium*  
            Kodiak Sciences Inc. KOD Director, 10% Owner 2022-01-21 0 2022-06-06 15,967,504    Premium*  
* Premium Members only  

Records found :    1397         Free Registration Required For Full Results.    Limit: 25

Download
  Page 11 of 56
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
RDEA Ardea Biosciences Inc 10% Owner   –       –       •   2008-04-17 4 B $13.28 $1,009 I/I 76 136,889 1.42 -
VPHM Viropharma Inc 10% Owner   –       –       •   2005-04-28 4 B $1.79 $1,020 I/I 570 1,175 1.42 -
INCY Incyte Corp Director   –       •       •   2008-12-17 4 B $3.15 $1,027 I/I 309 283,892 2.17 -
INCY Incyte Corp Director   –       •       •   2008-01-14 4 B $10.99 $1,033 I/I 94 282,043 2.17 -
ADLR Adolor Corp 10% Owner   –       –       •   2010-10-27 4 S $1.28 $1,037 I/I (802) 80,315 0 -
ACGN Aceragen, Inc 10% Owner   –       –       •   2007-12-11 4 S $12.25 $1,041 I/I (85) 30,405 0 -
ADLR Adolor Corp 10% Owner   –       –       •   2010-10-29 4 S $1.18 $1,046 I/I (884) 186,272 0 -
ADLR Adolor Corp 10% Owner   –       –       •   2010-10-28 4 S $1.19 $1,052 I/I (885) 79,430 0 -
RDEA Ardea Biosciences Inc 10% Owner   –       –       •   2005-04-12 4 B $3.57 $1,064 I/I 298 87,404 1.42 -
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2008-01-22 4 B $6.92 $1,113 I/I 161 2,440,598 1.42 -
GHDX Genomic Health Inc Director   –       •       •   2011-06-07 4 B $26.14 $1,125 I/I 43 194,339 2.17 -
SGEN Seagen Inc Director   –       •       •   2008-03-18 4 B $8.02 $1,131 I/I 141 477,382 2.17 -
VPHM Viropharma Inc 10% Owner   –       –       •   2005-01-31 4 B $3.02 $1,159 I/I 384 384 1.42 -
VPHM Viropharma Inc 10% Owner   –       –       •   2008-03-13 4 B $8.69 $1,165 I/I 134 144,103 1.42 -
GHDX Genomic Health Inc Director   –       •       •   2011-06-01 4 B $27.47 $1,209 I/I 44 194,296 2.17 -
GHDX Genomic Health Inc Director   –       •       •   2011-03-08 4 B $25.13 $1,256 I/I 50 152,640 2.17 -
VPHM Viropharma Inc 10% Owner   –       –       •   2009-05-11 4 B $5.86 $1,283 I/I 219 82,961 1.42 -
GHDX Genomic Health Inc Director   –       •       •   2011-06-09 4 B $26.25 $1,286 I/I 49 194,415 2.17 -
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2008-01-07 4 B $6.37 $1,301 I/I 190 190,207 1.42 -
GHDX Genomic Health Inc Director   –       •       •   2009-05-08 4 B $19.67 $1,318 I/I 67 193,954 2.17 -
RDEA Ardea Biosciences Inc 10% Owner   –       –       •   2006-01-24 4 B $5.98 $1,335 I/I 223 14,706 1.42 -
VPHM Viropharma Inc 10% Owner   –       –       •   2005-01-31 4 B $3.02 $1,362 I/I 451 451 1.42 -
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2008-01-18 4 B $7.15 $1,365 I/I 190 97,530 1.42 -
VPHM Viropharma Inc 10% Owner   –       –       •   2008-10-21 4 A $2.74 $1,397 I/I 510 130,084 0 -
SGEN Seagen Inc Director   –       •       •   2008-01-22 4 B $8.78 $1,404 I/I 160 475,914 2.17 -

  1397  Records found
  1   2   3   4   5   6   7   8   9   10   11  12   13   14   15   16   17   18   19   20   21   22   23   24   25   26   27   28   29   30   31   32   33   34   35   36   37   38   39   40   41   42   43   44   45   46   47   48   49   50   51   52   53   54   55   56      
  Page 11 of 56  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed